Loading clinical trials...
Loading clinical trials...
An Open Label, Multiple Ascending Dose Trial in Patients With T1DM to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Insulin Tregopil and to Evaluate the Postprandial Glucose Control With Different Meal Types in Comparison With Insulin Aspart
Conditions
Interventions
Tregopil
Locations
1
Germany
Profil Mainz GmbH & Co. KG Malakoff-Passage,Rheinstraße 4C D-55116
Mainz, Germany
Start Date
October 28, 2019
Primary Completion Date
April 23, 2021
Completion Date
April 23, 2021
Last Updated
June 27, 2022
NCT06819306
NCT07427134
NCT06845891
Lead Sponsor
Biocon Limited
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions